Evidence map›Paper›PMID 29671928›Full record

ArticlePsycho-oncology2018

Electronic cigarette use among patients with cancer: Reasons for use, beliefs, and patient-provider communication.

John B Correa, Karen O Brandon, Lauren R Meltzer, Hannah J Hoehn, Bárbara Piñeiro, Thomas H Brandon, Vani N Simmons

Open access · greenAbstract read
In one paragraph

Article in Psycho-oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Longitudinal Electronic Cigarette Use Among Patients Recently Diagnosed With Cancer Enrolled in a Smoking Cessation Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. E-cigarettes and Smoking Cessation in Smokers With Chronic Conditions.American journal of preventive medicine · 2019
    Article
  8. Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2019
    Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

John B CorreaDepartment of Psychology, University of South Florida, Tampa, FL, USA.
Karen O BrandonDepartment of Health Outcomes & Behavior, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Lauren R MeltzerDepartment of Health Outcomes & Behavior, H. Lee Moffitt Cancer Center, Tampa, FL, USA.ORCID 0000-0001-7600-6829
Hannah J HoehnDepartment of Health Outcomes & Behavior, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Bárbara PiñeiroOklahoma Tobacco Research Center, Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Thomas H BrandonDepartment of Psychology, University of South Florida, Tampa, FL, USA.
Vani N SimmonsDepartment of Psychology, University of South Florida, Tampa, FL, USA.
Moffitt Cancer Center · USUniversity of South Florida · USUniversity of Oklahoma Health Sciences Center · US

Funding

TRANSLATIONAL RESEARCHP30CA076292 · NCI · UNIVERSITY OF SOUTH FLORIDA · PI John L. Cleveland · 1998 to 2026
$93.5M
Smoking Relapse-Prevention Intervention for Cancer PatientsR01CA154596 · NCI · H. LEE MOFFITT CANCER CTR & RES INST · PI SIMMONS, VANI N · 2011 to 2015
$2.3M
NCI NIH HHS P30 CA076292NCI NIH HHS R01 CA154596
6 · The paper itself

Abstract

objectiveSmoking tobacco cigarettes after a cancer diagnosis increases risk for several serious adverse outcomes. Thus, patients can significantly benefit from quitting smoking. Electronic cigarettes are an increasingly popular cessation method. Providers routinely ask about combustible cigarette use, yet little is known about use and communication surrounding e-cigarettes among patients with cancer. This study aims to describe patterns, beliefs, and communication with oncology providers about e-cigarette use of patients with cancer.

methodsPatients with cancer (N = 121) who currently used e-cigarettes were surveyed in a cross-sectional study about their patterns and reasons for use, beliefs, and perceptions of risk for e-cigarettes, combustible cigarettes, and nicotine replacement therapies. Patient perspectives on provider communication regarding e-cigarettes were also assessed.

resultsMost participants identified smoking cessation as the reason for initiating (81%) and continuing (60%) e-cigarette use. However, 51% of patients reported current dual use of combustible cigarettes and e-cigarettes, and most patients reported never having discussed their use of e-cigarettes with their oncology provider (72%). Patients characterized e-cigarettes as less addictive, less expensive, less stigmatizing, and less likely to impact cancer treatment than combustible cigarettes (Ps < .05), and more satisfying, more useful for quitting smoking, and more effective at reducing cancer-related stress than nicotine replacement therapies (Ps < .05).

conclusionsPatients with cancer who use e-cigarettes have positive attitudes toward these devices and use them to aid in smoking cessation. This study also highlights the need for improved patient-provider communication on the safety and efficacy of e-cigarettes for smoking cessation.

Indexed as

Electronic Nicotine Delivery SystemsHealth CommunicationNeoplasmsProfessional-Patient RelationsSmokingSmoking CessationAdultAgedCross-Sectional StudiesFemaleFloridaHumansMaleMiddle Agedcancerdual usee-cigarettesoncologypatient-provider communicationsmoking cessation

Identifiers

PMID29671928
PMCPMC6043356
OpenAlexW2802422618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.